Literature DB >> 9410619

[Immunocytochemical venous blood studies in patients with manifest oral cavity carcinomas, oral precancerous conditions, benign tumors and in chronic alcoholic patients].

R Dammer1, E M Wurm, H Niederdellmann, H Fleischmann, R Knüchel.   

Abstract

In a prospective pilot study we investigated the percentage of immunocompetent cells in the peripheral blood in 146 patients (lymphocytes, leucocytes, monocytes, T cells, B cells, NK cells, T-helper cells, T-suppressor cells, ratio T-helper/T-suppressor cells, activated T cells HLA-DR) by flow cytometry. The immunologic parameters were derived from patients with oral and oropharyngeal squamous cell carcinomas, precancerous lesions and benign tumours and from a group of heavy smokers and alcoholics. Carcinoma patients (n = 46) were compared with risk groups and a reference group consisting of patients with inflammatory disease. Within the collective of carcinoma patients we measured the immune status before and after chemo-, radio- and operative therapy. We also analysed the immune parameters in relation to clinical and histomorphological parameters (TNM status, grading). The univariate analysis of monocytes showed significant relationships between on the one hand carcinoma patients and on the other alcoholics and those with benign tumours and precancerous lesions. In precancerous lesions NK cells were significantly increased compared with alcoholics and the reference group. A significant decrease in B cells in carcinoma patients may show incipient insufficiency of the humoral immunity. The immune parameters showed a different reaction depending on therapy. After irradiation we found a significant increase of T-suppressor cytotoxic cells and decreases in B and T-helper cells. Chemotherapy showed an increase in T and T-helper cells and a decrease in B cells. Surgical therapy alone yielded an increase in B cells. The comparison of all pre- and posttherapeutic parameters showed significant changes only in activated T cells HLA-DR. We found no correlation between prognostic clinico-pathological factors and immune parameters. No changes were found in a multivariate analysis.

Entities:  

Mesh:

Year:  1997        PMID: 9410619     DOI: 10.1007/BF03043522

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  44 in total

1.  [The question of polychemotherapy of oral tumors with curative and palliative objectives].

Authors:  B Langanke; R Dammer; R Bocher
Journal:  Stomatol DDR       Date:  1985-07

2.  [Cellular and humoral immune reactivity in patients with squamous cell carcinoma of the oral cavity].

Authors:  J Bier; U Nicklisch
Journal:  Dtsch Zahnarztl Z       Date:  1977-10

3.  Cellular immunity in patients with epidermoid cancer of the head and neck.

Authors:  P R Papenhausen; A Kukwa; C B Croft; B Borowiecki; C Silver; E E Emeson
Journal:  Laryngoscope       Date:  1979-04       Impact factor: 3.325

4.  Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements.

Authors:  F Hulstaert; I Hannet; V Deneys; V Munhyeshuli; T Reichert; M De Bruyere; K Strauss
Journal:  Clin Immunol Immunopathol       Date:  1994-02

5.  Natural killer cell activity and head and neck cancer: a clinical assessment.

Authors:  S P Schantz; E J Shillitoe; B Brown; B Campbell
Journal:  J Natl Cancer Inst       Date:  1986-10       Impact factor: 13.506

Review 6.  Immunobiologic aspects of head and neck cancer. Clinical and laboratory correlates.

Authors:  D R Vlock
Journal:  Hematol Oncol Clin North Am       Date:  1991-08       Impact factor: 3.722

7.  [HIV-associated dermatoses and their prevalence in 456 HIV-infected patients. Relation to immune status and its importance as a diagnostic marker].

Authors:  C Garbe; R Husak; C E Orfanos
Journal:  Hautarzt       Date:  1994-09       Impact factor: 0.751

8.  Patterns of recurrence from head and neck cancer. An immunologic perspective.

Authors:  S P Schantz; L J Peters
Journal:  Am J Clin Oncol       Date:  1987-12       Impact factor: 2.339

Review 9.  Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.

Authors:  T P Wustrow; H P Zenner
Journal:  Laryngoscope       Date:  1985-11       Impact factor: 3.325

10.  Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer.

Authors:  S P Schantz; B W Brown; E Lira; D L Taylor; N Beddingfield
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.